Surmodics, Inc. recently announced early results from its PROWL registry study of a subset of 60 real-world patients with acute ...
The study included 15 patients (9 men and 6 women) who underwent a total of 15 infrainguinal combined procedures between January 2000 and January 2004. The patients had a mean age of 68 years ...
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care ...
Medtronic (NYSE:MDT) announced results from two studies evaluating the utility of atherectomy for peripheral endovascular interventions.
Joseph Campbell, Interventional Cardiologist, OhioHealth, presented results from the infrainguinal PROWL subset. All patients in the 60-patient subset analysis were treated with the Pounce ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...